Authors | CNB result | Results after surgical resection | Upgrading to malignant cancer | |
---|---|---|---|---|
IDP with atypia (ADH/ALH) | DCIS | IDC/ILC | ||
Wiratkapun | 32 | 10 | 2 | 12 (38%) |
Rizzo | 42 | 14 | 2 | 16 (38%) |
Bianchi | 46 | 7 | 15 | 22 (48%) |
Authors | CNB result | Results after surgical resection | Upgrading to malignant cancer | ||
---|---|---|---|---|---|
IDP without atypia | Atypia (ADH or LN) | DCIS | IDC/ILC | ||
Wiratkapun | 52 | 17 (33%) | 0 | 0 | 0 |
Pareja | 171 | 39 (22.8%) | 2 | 2 | 4 (2.3%) |
Rizzo | 234 | 42 (17.9%) | 19 | 2 | 21 (9%) |
Bianchi | 68 | 19 (27.9%) | 5 | 4 | 9 (13.2%) |
Authors | CNB result | Results after surgical resection | Total number of upgraded cases | |
---|---|---|---|---|
ADH | DCIS | IDC | ||
Polat | 320 | 38 | 38 (11.5%) | |
McGhan | 114 | 14 | 6 | 20 (17.5%) |
Hsu | 134 | 46 | 7 | 53 (40%) |
Mesurolle | 50 | 13 | 15 | 28 (56%) |
Authors | False negative results in CNB | |
---|---|---|
Schulz | 37/205 | 18% |
Caswell-Smith | 59/287 | 20.6% |
Park | 21/69 | 30.4% |
Lee | 116/248 | 46.8% |